Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9802 | 1054 | 38.1 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CATHEPSIN K | Author keyword | 158 | 55% | 19% | 196 |
2 | PYCNODYSOSTOSIS | Author keyword | 84 | 87% | 4% | 41 |
3 | CATHEPSIN K INHIBITOR | Author keyword | 53 | 85% | 3% | 28 |
4 | ONO 5334 | Author keyword | 23 | 100% | 1% | 10 |
5 | ODANACATIB | Author keyword | 23 | 65% | 2% | 22 |
6 | CATHEPSIN S INHIBITOR | Author keyword | 20 | 100% | 1% | 9 |
7 | PYKNODYSOSTOSIS | Author keyword | 18 | 89% | 1% | 8 |
8 | DISCOVERY COMPUTAT ANALYT STRUCT SCI | Address | 14 | 100% | 1% | 7 |
9 | WORLD WIDE PHYS PROPERTIES | Address | 13 | 80% | 1% | 8 |
10 | GENE EXP S PROT PURIFICAT | Address | 11 | 100% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CATHEPSIN K | 158 | 55% | 19% | 196 | Search CATHEPSIN+K | Search CATHEPSIN+K |
2 | PYCNODYSOSTOSIS | 84 | 87% | 4% | 41 | Search PYCNODYSOSTOSIS | Search PYCNODYSOSTOSIS |
3 | CATHEPSIN K INHIBITOR | 53 | 85% | 3% | 28 | Search CATHEPSIN+K+INHIBITOR | Search CATHEPSIN+K+INHIBITOR |
4 | ONO 5334 | 23 | 100% | 1% | 10 | Search ONO+5334 | Search ONO+5334 |
5 | ODANACATIB | 23 | 65% | 2% | 22 | Search ODANACATIB | Search ODANACATIB |
6 | CATHEPSIN S INHIBITOR | 20 | 100% | 1% | 9 | Search CATHEPSIN+S+INHIBITOR | Search CATHEPSIN+S+INHIBITOR |
7 | PYKNODYSOSTOSIS | 18 | 89% | 1% | 8 | Search PYKNODYSOSTOSIS | Search PYKNODYSOSTOSIS |
8 | CATHEPSIN K INHIBITORS | 9 | 64% | 1% | 9 | Search CATHEPSIN+K+INHIBITORS | Search CATHEPSIN+K+INHIBITORS |
9 | CATHEPSIN S | 9 | 12% | 7% | 69 | Search CATHEPSIN+S | Search CATHEPSIN+S |
10 | CTSK | 7 | 67% | 1% | 6 | Search CTSK | Search CTSK |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PYCNODYSOSTOSIS | 125 | 79% | 8% | 81 |
2 | ARYLAMINOETHYL AMIDES | 72 | 100% | 2% | 23 |
3 | PYKNODYSOSTOSIS | 31 | 92% | 1% | 12 |
4 | RESORBING COMPARTMENT | 29 | 88% | 1% | 14 |
5 | HUMAN OSTEOCLASTS | 28 | 56% | 3% | 35 |
6 | ODANACATIB | 23 | 74% | 2% | 17 |
7 | RESORBING AGENTS | 17 | 79% | 1% | 11 |
8 | CATHEPSIN K DEFICIENCY | 15 | 68% | 1% | 13 |
9 | LYSOSOMOTROPISM | 15 | 88% | 1% | 7 |
10 | CATHEPSIN K INHIBITOR | 14 | 39% | 3% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis | 2011 | 56 | 80 | 81% |
Cathepsin K inhibitors for osteoporosis and potential off-target effects | 2009 | 53 | 124 | 72% |
Clinical and radiographic maxillofacial features of pycnodysostosis | 2014 | 2 | 13 | 100% |
Cathepsin K: a unique collagenolytic cysteine peptidase | 2013 | 14 | 123 | 60% |
Cathepsin S inhibitors: 2004-2010 | 2011 | 19 | 54 | 76% |
The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics | 2005 | 146 | 142 | 39% |
Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011 | 2011 | 16 | 85 | 79% |
Cathepsins and cystatin C in atherosclerosis and obesity | 2010 | 34 | 55 | 44% |
Cathepsin cysteine proteases in cardiovascular disease | 2007 | 122 | 91 | 34% |
Recent Advances in the Design of Cathepsin S Inhibitors | 2010 | 18 | 48 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISCOVERY COMPUTAT ANALYT STRUCT SCI | 14 | 100% | 0.7% | 7 |
2 | WORLD WIDE PHYS PROPERTIES | 13 | 80% | 0.8% | 8 |
3 | GENE EXP S PROT PURIFICAT | 11 | 100% | 0.6% | 6 |
4 | CLIN DEV PLANNING | 5 | 63% | 0.5% | 5 |
5 | EXPT ORAL BIOL GRP | 4 | 75% | 0.3% | 3 |
6 | SECT OXIDAT ST S INFLAMMAT | 3 | 100% | 0.3% | 3 |
7 | CLIN CELL BIOL KCB | 3 | 50% | 0.4% | 4 |
8 | VEJLE LILLEBAELT HOSP | 3 | 60% | 0.3% | 3 |
9 | PHYS STRUCT CHEM | 2 | 18% | 1.0% | 11 |
10 | BONE CARTILAGE BIOL | 2 | 15% | 1.1% | 12 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228799 | CATHEPSIN B//CATHEPSIN L//CATHEPSIN X |
2 | 0.0000129734 | TARTRATE RESISTANT ACID PHOSPHATASE//SPECIAL HEMATOL//TARTRATE RESISTANT |
3 | 0.0000097896 | RANKL//OSTEOCLAST//OSTEOCLASTOGENESIS |
4 | 0.0000094035 | OSTEOPETROSIS//MALIGNANT INFANTILE OSTEOPETROSIS//TCIRG1 |
5 | 0.0000082060 | TUMOR TISSUE PROGRESSION//FIBROBLAST COLLAGENASE//CARRAGEENAN GRANULOMA |
6 | 0.0000048036 | TERIPARATIDE//PTH//REG BONE |
7 | 0.0000047900 | ALLIED MED SCI SUMA KU//MED FUKUSHIMA KU//TARUMI KU |
8 | 0.0000047775 | DRYNARIA FORTUNEI//DRYNARIAE RHIZOMA//DRYNARIA QUERCIFOLIA |
9 | 0.0000042186 | POSITIVE BONE BALANCE//PROSTAGLANDIN ESTRADIOL PGE2//ENDOCRINOL METAB MC1850 |
10 | 0.0000040645 | GROWTH HORMONE BIOL//IN SITU SETTING CEMENT//POLYD L LACTIDE COATING |